Bone Morphogenetic Proteins

All categories
DBCAT002859Pharmacologic classM05BC

Bone-growth regulatory factors that are members of the transforming growth factor-beta superfamily of proteins. They are synthesized as large precursor molecules which are cleaved by proteolytic enzymes. A DrugBank category of 2 drugs. 2 of them are approved.

ATC classification
Also known as
Bone Morphogenetic Protein · Morphogenetic Protein, Bone · Morphogenetic Proteins, Bone
Drugs

What you can answer from here — as of January 23, 2018

2DrugsEach linked to its full drug card
Listed above
6Drug targetsEvery drug–target pair in the class, with bond type
Sign in
9Marketed productsAcross the regions we cover, with dosage forms and routes
Sign in
2Routes of administrationHow the drugs in this class are given
Sign in

Which targets do Bone Morphogenetic Proteins share, and which companies have late-stage candidates in this class?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In